The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

May 20, 2025

Study Completion Date

May 26, 2025

Conditions
Magnesium SulfatePregnancy; Pre-EclampsiaNeuromuscular Blockade
Interventions
DRUG

pregnant women taking magnesium

The patient group who received magnesium as a 4-6 g loading and 2-3 g/h maintenance dose to prevent convulsions in preeclampsia. Pregnant will be operated under general anesthesia. Sugammadex 4mg/kg will be administered when TOF 0 response is seen at the end of surgery. The time from TOF 0 to TOF 0.9 will be recorded. Magnesium and calcium levels in the blood will be studied.

DRUG

Placebo

Pregnant women who do not receive magnesium therapy and who will be operated under general anesthesia. Sugammadex 4mg/kg will be administered when TOF 0 response is seen at the end of surgery. The time from TOF 0 to TOF 0.9 will be recorded. Magnesium and calcium levels in the blood will be studied.

Trial Locations (1)

26040

Eskisehir Osmangazi Universıty Faculty of Medicine, Eskişehir

All Listed Sponsors
lead

Eskisehir Osmangazi University

OTHER